Hyderabad, April 25 (UNI) Dr. Reddy’s Laboratories and Nestlé India have entered into a definitive agreement to form a joint venture company to bring innovative nutraceutical brands to consumers in India and other agreed territories.
The partnership will combine the well-known global range of nutritional health solutions as well as vitamin, minerals, herbals and supplements (VMHS) of Nestlé Health Science (NHSc) and the strong and established commercial strengths of Dr. Reddy’s in India.
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios in categories such as metabolic, hospital nutrition, general wellness , women’s health and child nutrition for consumers across India, Hyderabad based pharma giant Dr Reddy Laboratories said in a release here on Thursday.
The JV Company, to be headquartered in Hyderabad, will leverage the capabilities as well as services of the Nestlé Group and Dr. Reddy’s and select brands will be licensed by the JV Partners to the JV company.
The Nestlé Group will license brands such as Nature’s Bounty, Osteo Bi-Flex, Ester-C, Resource High Protein, Optifast, Resource Diabetic, Peptamen, Resource Renal and Resource Dialysis.
Dr. Reddy’s Labs will license brands such as Rebalanz, Celevida, Antoxid, Kidrich-D3, Becozinc in the nutrition, and OTC segments. The JV Company is expected to become operational in Q2 of FY’25.
Commenting on the joint venture, Mr. Suresh Narayanan, Chairman and Managing Director, Nestlé India said, “This joint venture is another important step in that direction, allowing us to bring our science-backed nutritional solutions to more people across the country.
Dr. Reddy’s is a trusted name in the pharmaceutical space and shares our commitment to provide access to high quality products. This joint venture will enable us to build a robust retail and distribution network to take our brands closer to consumers and make a meaningful difference to improve the quality of life,” he added.
M.V. Ramana, CEO – Branded Markets (India & Emerging Markets), Dr. Reddy’s said, “This joint venture is a novel approach by two companies that have a shared purpose of good health. We are pleased to partner with Nestlé India to bring innovations from the Nestlé Health Science global portfolio to consumers in India.
This novel approach of leveraging mutually complementary strengths of both parent companies will enable better access and affordability for consumers.”
UNI KNR CS1430